Clinical and epidemiologic features of Guillain-Barre syndrome

Journal of Infectious Diseases

Volumn 176, Issue 6 SUPPL., 1997, Pages

  Hughes, Richard A C ^a   Rees, Jeremy H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPYLOBACTER JEJUNI; CONFERENCE PAPER; EPIDEMIC; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; NERVE FIBER DEGENERATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION;

EID: 0030723101     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513793     Document Type: Conference Paper

References (8)

1. Asbury AK, Arnason BGW, Karp HR, McFarlin DF. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3:565-6.
2. Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981; 9(suppl): 1-5.
3. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4.
4. Hughes RAC. Guillain-Barré syndrome. Heidelberg, Germany: Springer-Verlag, 1990.
5. Fisher M. Syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med 1956;255:57-65.
6. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis, 1991.
7. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-16.
8. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349: 225-30.